Company profile
Sweet Earth Holdings Corporation
OTC: SEHCF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Vancouver, BCReports USD
#1166 of 1,422 Healthcare companies by revenuebottom-decile growth
EA Score
22DFH 19DQ —GM 25SS 36
v0.1 · 45/100 weight · provisional
↑ growth stability, return on assets · ↓ revenue growth (YoY), 3-yr revenue growth
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
-100.0%
Net income (FY)
-$763.8k
Employees
—
as of 2026-08-23
Market cap
$6.4M
as of 2026-08-23
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$00 CAD2025
Net income-$763.8k-1.1M CAD2025
Operating income-$751.7k-1.0M CAD2025
Total assets$1.5M2.1M CAD2025
Liabilities$2.1M2.9M CAD2025
Equity-$4.5k-6.1k CAD2025
Revenue trend
FY2019 – FY2025 · USD
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Sweet Earth Holdings Corporation’s revenue?
Sweet Earth Holdings Corporation booked $0 in FY2025 revenue, contracting 100% year over year — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.
Peers · Healthcare
Vynleads, Inc.20DModular Medical, Inc.34DExicure, Inc.31DProcessa Pharmaceuticals, Inc.39DPharmaCyte Biotech, Inc.——ENDRA Life Sciences Inc.25DKey facts
CEORobert Dubeau
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersVancouver, BC
ExchangeOTC: SEHCF
Employees—
IPO date2020-09-23
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.